Health News Releases

  • Today July 1
Rachel Nordberg, PhD, from the DELTAi Lab at UC Irvine, prepping the BioServe device before it goes
June 30, 13:50
Cartilage Tissue Engineering Heads to Orbit in NSF and NASA-supported Study at the International Space Station
Researchers in the DELTAi Lab at the University of California, Irvine (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fsites.uci.edu%2Fdeltai%2F&esheet=54561327&newsitemid=2026062954
June 29, 09:34
DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion followin
Burjeel Holdings’ inaugural Sukuk was priced at a 7.000 % profit rate and a yield of 7.125% (Photo:
June 28, 14:55
Burjeel Holdings Prices First MENA Healthcare Sukuk Since 2018, 3.2x Oversubscribed
The offering attracted significant demand from high-quality international and regional investors, with the orderbook peaking at USD 1.6 billion, representing 3.2x oversubscription. The strength of the
June 26, 11:30
MRM Health Strengthens Board with Michel Detheux as Chairman and Hans-Jürgen Wörle as Independent Director as MH002 Advances Through Phase 2b
MRM Health, a clinical-stage biotech developing microbiome-based therapies for immune-mediated diseases, today announced the appointment of two experienced industry leaders to its Board of Directors a
June 24, 16:32
Takeda Announces New Assignments of Directors and Appointment of Julie Kim as Representative Director, President and CEO
In the final step of its 18-month CEO transition, Takeda (TOKYO:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&eshee
June 24, 08:51
Merck Collaborates with Versant Ventures to Launch Saturnus Bio to Advance Treatments for Rare Genetic Cardiomyopathies
Merck, a leading global science and technology company, today announced a strategic research-stage collaboration with Saturnus Bio, a Versant Ventures-founded biotech, aimed at establishing a foundati
June 23, 11:30
HistoSonics Announces Financing with Participation from Yosemite Among Other Strategic Investors
HistoSonics (https://histosonics.com/?utm_source=chatgpt.com), the developer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the closing of a new financing r
Cytiva × CellFiber | Next-Generation Stem Cell Manufacturing & Commercialization Strategy Workshop
June 22, 14:00
CellFiber to Co-Host Next-Generation Stem Cell Manufacturing and Commercialization Workshop with Cytiva in Korea
CellFiber will jointly host the Next-Generation Stem Cell Manufacturing and Commercialization Strategy Workshop with Cytiva on Wednesday, 15 July 2026 at the Cytiva APAC Fast Trak™ Center in Songdo, I
June 19, 11:01
Astrogen, inc. Validates Autism Spectrum Disorder Research with Prestigious Folia Award
Astrogen, inc. (https://astrogen.co.kr/eng/index.html), a leading biotech company in South Korea, said that it has received the “Folia Award (https://onlinelibrary.wiley.com/doi/toc/10.1111/) (ISSN)14
June 17, 15:55
BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit
BeOne Medicines Ltd. (https://beonemedicines.com/) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced the presentation of a large Phase 3 dataset in patients with chro
Biocytogen Earns Full AAALAC Accreditation, Reinforcing Excellence in Translational Research and Dru
June 17, 11:30
Biocytogen Earns Full AAALAC Accreditation, Reinforcing Excellence in Translational Research and Drug Discovery
Biocytogen today announced that its Boston research facility has been awarded Full Accreditation by AAALAC International, a globally recognized organization dedicated to promoting excellence in labora
June 16, 16:55
New Pivotal Study Data Show Takeda’s Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for People with Narcolepsy Type 1
Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54552126&newsitemid=20260615651327&lan=en-US&ancho
June 16, 08:55
SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated June 10, 2026 (
Syngenta Country Head for France Anne Azam (2nd from right) with India’s Minister of Commerce and In
June 15, 16:45
Syngenta Signs MoU to Be Strategic Partner in India’s First Open-Data Agricultural Ecosystem Annam.AI
India’s agriculture sector is a global powerhouse, uniquely characterized by its massive scale, vast arable land, diverse agro-climatic zones and rich biodiversity. These strengths have propelled the
June 15, 11:10
BeOne Medicines’ Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 2026
BeOne Medicines Ltd. (https://beonemedicines.com/) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from its foundational hematology franchise at the 2026 E
Visit Roquette at booth E3D26 to meet with its team of experts
June 12, 16:50
Roquette Showcases Scalable Drug Delivery Innovations at CPHI China 2026
Roquette, a global leader in plant-based ingredients and pharmaceutical excipients, will showcase its comprehensive portfolio of innovative drug delivery solutions at CPHI & PMEC China 2026, taking pl
June 12, 15:20
Parse Biosciences Launches the Next Generation of its Immune Profiling Kits
Parse Biosciences (https://www.parsebiosciences.com/), the leading provider of scalable and accessible single cell sequencing solutions, today launched the next generation of its Evercode™ TCR (https:
June 12, 15:10
Merrithew® Expands Global Mindful Movement Leadership with Acquisition of the GYROTONIC® Organization
Merrithew®, a global leader in mindful movement education and equipment and creator of internationally recognized programs including STOTT PILATES®, ZEN·GA®, Halo® Training and Total Barre®, today ann
June 12, 11:20
Cosylab and Heron Neutron Medical Corp. Sign Letter of Intent to Advance Global Deployment of Accelerator-Based BNCT Systems
Cosylab and Heron Neutron Medical Corp. announced today, 10 June 2026, the signing of a Letter of Intent to establish a strategic framework for joint market development to support the global deploymen
June 12, 10:51
Takeda’s Zasocitinib Significantly Outperforms Deucravacitinib in Head-to-Head Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations
Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) announced positive topline results for the Phase 3, randomized, multicenter, double-blind study comparing zasocitinib (TAK-279),
June 11, 14:45
Galderma Unveils New Global Survey Data Exploring the Evolving Expectations and Experiences of Patients and Healthcare Professionals With Anti-wrinkle Treatments
Galderma (SIX: GALD) has released findings from a landmark global survey conducted across the United States (U.S.), Brazil, the United Kingdom (UK), and China - the largest of its kind - exploring the
Cover of the June 2026 issue of Crystal Growth & Design, featuring this research.
June 10, 16:45
New Polymorph of Indomethacin Discovered
Rigaku Corporation, a global solution partner in X-ray analytical systems and a group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; “Rigaku”), announced tha
Oral-B iO9 Black
June 10, 15:00
New Study Reveals the True Environmental Impact of Periodontal Disease - And What You Can Do About It
Today P&G Oral Care announces the release of a new, first-of-its kind LCA study published in the Journal of Dentistry finds managing advanced periodontal disease can be associated with up to ~10× high
June 10, 15:00
Neuraptive Therapeutics, Inc. Announces Key Organizational Updates to Support the Company’s Advancement Toward Commercialization
Neuraptive Therapeutics today announced the appointment of Ulf Wiinberg to its Board of Directors and William “Bill” MacKenzie as Senior Vice President - Finance. Mr. Wiinberg is a seasoned biotech
June 10, 14:00
Shilpa Medicare and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy
Shilpa Biocare Pvt Ltd, a Subsidiary of Shilpa Medicare Limited (BSE/NSE: SHILPAMED) has entered a strategic equity partnership with Gate2Brain, S.L., a biotechnology company focused on CNS therapeuti
June 10, 12:00
Haleon Invests in India to Deliver Better Everyday Health to Rural Communities
Haleon, a consumer company that is solely focused on better everyday health, today announces plans to expand its business in India, one of its fastest-growing markets and key to Haleon delivering its
June 09, 17:45
Cosylab Launches PlanOne™ Treatment Planning System for Particle Therapy
Cosylab today announced the commercial launch of PlanOne™, a treatment planning system for particle therapy, bringing physics-accurate, radiobiologically informed planning and a unified clinical workf
June 09, 13:30
Diabetology’s Breakthrough Clinical Data From Oraglutide™ Oral GLP-1
Diabetology Limited (Jersey) poster presentation (https://diabetology.co.uk/ada-poster) 1724-P at the ADA 86th Scientific Session, New Orleans, reporting first human data from Oraglutide™ — small caps
June 05, 11:30
New Evidence Offers Hope for Ketogenic Therapy in Treatment of Anorexia Nervosa
A pilot study published today in Communications Medicine (https://www.nature.com/articles/s43856-026-01644-0) demonstrates the potential of a new approach to treating anorexia nervosa — a disorder for
June 03, 13:00
BeOne Medicines Highlights Accelerating Solid Tumor Pipeline with New Data at ASCO 2026
BeOne Medicines Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fbeonemedicines.com%2F&esheet=54545081&newsitemid=20260601948824&lan=en-US&anchor=BeOne+Medicines+Ltd.&index=1&md5
June 01, 15:35
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 2026
BeOne Medicines Ltd. (https://beonemedicines.com/) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the
May 31, 12:25
Rubedo’s RLS-1496 Reduces Actinic Keratosis Pre-Cancerous Skin Lesions by 46% at Four Weeks with Minimal Irritation in Preliminary Results of Phase 1b/2a Study
Rubedo Life Sciences, Inc. (https://www.rubedolife.com/) (Rubedo), an AI-driven, clinical-stage biotech focused on selective cellular rejuvenation medicines targeting aging cells, today announced prel
May 31, 11:43
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (t
May 31, 11:40
AAHI’s SLA-SE Adjuvant Technology Powers Lilly’s Acquisition of Curevo’s Next-Generation Shingles Vaccine
The Access to Advanced Health Institute (AAHI), a nonprofit biotech organization dedicated to developing vaccines and technologies for global health, today congratulates Eli Lilly and Company and Cure
May 29, 12:00
BeOne Medicines Announces Phase 3 HERIZON-GEA Data Published in NEJM and Presented at ASCO 2026
BeOne Medicines Ltd. (https://beonemedicines.com/) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that data from HERIZON-GEA-01 were published in The New England J
May 29, 10:00
Brenus Pharma Announces FDA Acceptance of IND Application for STC-1010 (BreAK-CRC001) in MSS Metastatic Colorectal Cancer (mCRC)
Brenus Pharma, a clinical stage biotechnology company developing novel in vivo immunotherapies for solid tumors, announced that the U.S. Food and Drug Administration (FDA) (https://www.fda.gov/) has a
Parse Biosciences and bit.bio Announce Landmark Alliance
May 28, 14:00
Parse Biosciences and bit.bio Announce Landmark Alliance
Parse Biosciences (https://www.parsebiosciences.com/), the leading provider of scalable and accessible single cell sequencing solutions, today announced an alliance with bit.bio (https://www.bit.bio/)
Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discov
May 27, 17:10
Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated librar
May 27, 16:30
Mevion Medical Systems and Tam Anh General Hospital Partner to Bring Advanced Proton Therapy to Vietnam
Mevion Medical Systems has signed a definitive purchase agreement to bring the MEVION S250-FIT Proton Therapy System™ to Tam Anh General Hospital in Vietnam. This would be the first proton therapy sys
May 26, 16:00
BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026 with 60+ Abstracts
BeOne Medicines Ltd. (https://beonemedicines.com/) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that more than 60 abstracts across hematologic malignancies and s
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly
May 25, 14:15
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning s
May 25, 13:55
Polpharma Biologics and Tuteur Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases
Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, today announced the signing of a landmark licensing agreement with Argentina-
Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psy
May 25, 13:15
Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis
Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patien
The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch
May 25, 13:10
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1
May 22, 15:30
HistoSonics Receives Landmark TFDA Approval in Taiwan, Accelerating Global Expansion
HistoSonics (https://histosonics.com/), the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced it has received approval from the Taiwan Food and Drug A
May 22, 09:51
SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nomin
BeOne Medicines' One Save Changes Everything campaign uses soccer as a lens to recognize the scient
May 21, 15:30
BeOne Medicines Launches One Save Changes Everything, a Global Cancer Care Awareness Campaign with Soccer Legend Tim Howard
BeOne Medicines Ltd. (https://beonemedicines.com/) (“BeOne”) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today launched One Save Changes Everything (https://beonemedicines.com/
Maria Paola Chiesi is appointed Chair of Chiesi Board of Directors, the first woman in this role; ai
May 21, 08:35
Chiesi Group Announces New Chair and Vice Chair
Chiesi today announced a planned leadership change in its Board of Directors: Maria Paola Chiesi has been appointed Chair of the Board, succeeding Alessandro Chiesi, who is completing his tenure after
May 20, 16:40
InterSystems IntelliCare Becomes the First AI-Native EHR to Achieve EU Medical Device Regulation Certification
InterSystems (https://www.intersystems.com/), a creative data technology provider powering more than one billion health records globally, today announced that its electronic health record (EHR) soluti
May 20, 11:35
Samsung Bioepis Launches Ustekinumab Biosimilar, Marking Its First Product Launch in Japan
Samsung Bioepis Co., Ltd. today announced the launch of Ustekinumab BS 45 mg Syringe for S.C. Injection ‘NIPRO’, a biosimilar referencing Stelara[1] (ustekinumab), marking its first product launch in
25 per page50 per page75 per page100 per page